Investing

SAGA Metals Corp.Opens the Market

Mike Stier, Chief Executive Officer and Director, Saga Metals Corp. and Michael Garagan, Chief Geological Officer and Director, Saga Metals Corp. (‘SAGA’ or the ‘Company’) (TSXV: SAGA), joined Rob Peterman, Chief Commercial Officer, Toronto Stock Exchange, to open the market to celebrate the company’s new listing on TSX Venture Exchange.

SAGA is a diversified critical mineral exploration company focused on exploration and discovery of critical minerals that support the global transition to green energy. The company’s flagship asset, the Double Mer Uranium Project, features uranium radiometrics highlighting an 18 km trend, with a confirmed 14 km section producing samples as high as 4,281ppm U3O8 and spectrometer readings of 22,000cps. In addition to its uranium focus, SAGA owns the Legacy Lithium Property in Quebec’s Eeyou Istchee James Bay. The Legacy project, developed in partnership with Rio Tinto, has been expanded through the acquisition of the Amirault Lithium Project. Together, these properties cover 65,849 hectares and share significant geological continuity with other major players in the area. SAGA is strategically positioned to play an essential role in the clean energy future.

MEDIA CONTACT:
Mike Stier
Chief Executive Officer and Director
mike@sagametals.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/228925

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 GreatWallStreetPublisher.com

Exit mobile version